MiRNA profiling of LNCaP cells treated with bortezomib or celastrol against untreated control group
Ontology highlight
ABSTRACT: This study is designed for exploring miRNAs affected by proteasome inhibitor treatment. LNCaP cells were treated with 100nM bortezomib or 2.5 uM celastrol for 12 hrs, and was subjected to miRNA profiling assay.
ORGANISM(S): Homo sapiens
SUBMITTER: Hui Wang
PROVIDER: E-MTAB-6215 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA